Analyst Ratings for Gracell Biotechnologies Inc (GRCL)

GRCL Rating Summary

GRCL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GRCL
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $34.50 (+212.2%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/3/2021 Citi Mohit Bansal New Coverage Buy
(N/A)
35.00
(N/A)
25.96
(11.05)
-57.43% Details
2/2/2021 Wells Fargo N/A New Coverage Overweight
(N/A)
33.00
(N/A)
21.81
(11.05)
-49.34% Details